top of page
Patient-centric
Value Proposition
Pebble Life Science is replacing chemotherapy for ovarian, breast & colorectal cancer patients with nontoxic, more effective, inexpensive natural product isolates; designed to be easy to manufacture, distribute, and administer via dry-fill capsules.​ ​​​
​The direct benefit to patients will be a significant improvement in both overall survival and quality of life.
Scalability
The corporate benefit is global, reaching exponentially more patients due to lower supply chain costs and product stability.
Differentiated Advantage
Pebble is the requisite scarce commodity: a hungry, focused, dedicated team able and willing to solve the sequential challenges that create the monopolistic, differentiated advantage of a new cancer treatment modality.
bottom of page